The estimated Net Worth of Hasan Jafri is at least $15 dollars as of 4 May 2023. Dr Jafri owns over 10,000 units of Aridis Pharmaceuticals Inc stock worth over $15 and over the last 4 years he sold ARDS stock worth over $0.
Dr has made over 2 trades of the Aridis Pharmaceuticals Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he exercised 10,000 units of ARDS stock worth $10 on 4 May 2023.
The largest trade he's ever made was exercising 10,000 units of Aridis Pharmaceuticals Inc stock on 4 May 2023 worth over $10. On average, Dr trades about 1,888 units every 76 days since 2020. As of 4 May 2023 he still owns at least 15,100 units of Aridis Pharmaceuticals Inc stock.
You can see the complete history of Dr Jafri stock trades at the bottom of the page.
Dr. Hasan Jafri M.D. is the Chief Medical Officer at Aridis Pharmaceuticals Inc.
Hasan's mailing address filed with the SEC is C/O ARIDIS PHARMACEUTICALS, INC., 983 UNIVERSITY AVE, BLDG. B, LOS GATOS,, CA, 95032.
Over the last 6 years, insiders at Aridis Pharmaceuticals Inc have traded over $0 worth of Aridis Pharmaceuticals Inc stock and bought 1,445,847 units worth $181,502 . The most active insiders traders include Vu Truong, Eric Patzer, and Fred Kurland. On average, Aridis Pharmaceuticals Inc executives and independent directors trade stock every 89 days with the average trade being worth of $125. The most recent stock trade was executed by Eric Patzer on 24 June 2024, trading 714,286 units of ARDS stock currently worth $50,000.
aridis is a privately held infectious diseases focused company in san jose, ca, usa. aridis’ advanced formulation and delivery technologies are combined with proprietary products portfolio to create potent drug candidates that are packaged into convenient to administer, "ready-to-use" formats.
Aridis Pharmaceuticals Inc executives and other stock owners filed with the SEC include: